Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 double-blind study of propofol with/without EES0000645/A for moderate sedation during gastrointestinal endoscopy
jRCT2080222312Phase 3
- Sponsor
- AstraZeneca
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial comparing Propofol + EES0000645/A with Propofol + placebo (2 arms).
02
Drugs
propofol
Beyond the preview
Go deeper on jRCT2080222312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222312.